等待開盤 07-23 09:30:00 美东时间
+0.240
+0.59%
Wells Fargo analyst Elyse Greenspan maintains Baldwin Insurance (NASDAQ:BWIN) with a Underweight and raises the price target from $34 to $36.
07-10 22:43
An official report on July 3, 2025 reveals Representative Scott Franklin's rece...
07-04 23:00
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140565699993591809.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 丰业银行:维持乌龙制药(URGN)"跑赢大市"评级,目标价从23美元升至47美元</p> <p>• Guggenheim:维持ADC Therapeutics(ADCT)"买入"评级,目标价从7美元升至10美元</p>
06-16 08:40
Hippo's Homebuilder Distribution Network Adds 8 New Homebuilders to Westwood's Client Roster; At Closing, Westwood Will Power the Home Insurance Experience for 20 of the Top 25 Homebuilders Representing Over 35% of Total
06-12 19:09
An official report on June 2, 2025 reveals Representative Scott Franklin's rece...
06-03 23:00
Corporate earnings continued to drive the biggest movers across financial stocks this week, which was also marked by signs of easing trade tensions and the Federal Reserve still in wait-and-see mode. ...
05-10 22:10
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117736711687032832.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 杰富瑞:上调内克塔治疗(NKTR)评级至"买入",目标价从1美元升至2美元</p> <p>• Roth MKM:维持Lovesac Co.(LOVE)"买入"评级,目标价从22美元升至28美元</p> <p>• Macq
04-14 07:05
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117373634651086848.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity:维持Travere Therapeutics(TVTX)"买入"评级,目标价从45美元升至47美元</p> <p>• JMP证券:维持Benitec生物制药(BNTC)"跑赢大市"评级,
04-11 09:36
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Pacira BioSciences(PCRX)"买入"评级,目标价从48美元升至65美元</p> <p>• 瑞穗:上调Amylyx Pharmaceuticals(AM
04-09 08:50
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112300378952404993.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer:维持Corvus Pharma(CRVS)"跑赢大市"评级,目标价从14美元升至15美元</p> <p>• 富国银行:上调Regulus Therapeutics(RGLS)评级至"超配",目标价从
03-28 09:06